Evan A. Thackaberry
Corporate Officer/Principal at VIGIL NEUROSCIENCE, INC.
Net worth: 4 770 $ as of 2024-05-30
Evan A. Thackaberry active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Corporate Officer/Principal | 2020-08-31 | - |
Career history of Evan A. Thackaberry
Former positions of Evan A. Thackaberry
| Companies | Position | Start | End |
|---|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-09-30 | 2020-02-29 |
Training of Evan A. Thackaberry
| University of Wisconsin | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Evan A. Thackaberry
- Experience
